Deep Medicine Acquisition (Deep Medicine Acquisition) FCF Yield % : -7.15 (As of May. 19, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Deep Medicine Acquisition FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Deep Medicine Acquisition's Trailing 12-Month Free Cash Flow is $-1.00 Mil, and Market Cap is $13.95 Mil. Therefore, Deep Medicine Acquisition's FCF Yield % for today is -7.15%.

The historical rank and industry rank for Deep Medicine Acquisition's FCF Yield % or its related term are showing as below:

DMAQ' s FCF Yield % Range Over the Past 10 Years
Min: -7.15 Med: 0 Max: 0
Current: -7.15

DMAQ's FCF Yield % is not ranked
in the Diversified Financial Services industry.
Industry Median: -1.425 vs DMAQ: -7.15

Deep Medicine Acquisition's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

Deep Medicine Acquisition FCF Yield % Historical Data

The historical data trend for Deep Medicine Acquisition's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deep Medicine Acquisition FCF Yield % Chart

Deep Medicine Acquisition Annual Data

Trend

Mar21

Mar22

Mar23

FCF Yield %

-0.43

-2.11

Deep Medicine Acquisition Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Yield %	Get a 7-Day Free Trial							-0.47	-2.51	-3.00	-0.41	-2.11

Competitive Comparison of Deep Medicine Acquisition's FCF Yield %

For the Shell Companies subindustry, Deep Medicine Acquisition's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deep Medicine Acquisition's FCF Yield % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Deep Medicine Acquisition's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Deep Medicine Acquisition's FCF Yield % falls into.

Deep Medicine Acquisition FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Deep Medicine Acquisition's FCF Yield % for the fiscal year that ended in Mar. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1.036	/	48.9944142
	=	-2.11%

Deep Medicine Acquisition's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.269	*	4	/	50.988132
	=	-2.11%

Deep Medicine Acquisition FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Deep Medicine Acquisition FCF Yield % Related Terms

Thank you for viewing the detailed overview of Deep Medicine Acquisition's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Deep Medicine Acquisition (Deep Medicine Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

595 Madison Avenue, 12th Floor, New York, NY, USA, 10017

Website

Deep Medicine Acquisition Corp is a blank check company.

Executives

John Chiang	director	3538 TORRANCE BLVD., UNIT 177, TORRANCE CA 90503
Bryant Fong	director	2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Humphrey P Polanen	director, officer: Chief Executive Officer	C/O HERITAGE COMMERCE CORP, 150 ALMADEN BLVD, SAN JOSE CA 95113
Weixuan Luo	officer: Chief Financial Officer	40 WALL STREET, 29TH FLOOR, NEW YORK NY 10005
Marc Hamer	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Bright Vision Sponsor Llc	10 percent owner	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Ronald M. Razmi	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Hongliang Ren	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Wanlei Miao	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Tina Spires	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017